scholarly article | Q13442814 |
P2093 | author name string | Hiroshi Uchi | |
P2860 | cites work | T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus | Q24645091 |
Clonal integration of a polyomavirus in human Merkel cell carcinoma | Q24657675 | ||
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. | Q27853379 | ||
Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs | Q28073445 | ||
Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature | Q28247090 | ||
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas | Q28270523 | ||
Merkel cell carcinoma: incidence, mortality, and risk of other cancers | Q42470781 | ||
Merkel cell polyomavirus in cutaneous swabs | Q42553271 | ||
Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010. | Q43500752 | ||
Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study | Q44461515 | ||
Merkel cell carcinoma: a clinicopathological study of 11 cases | Q44955605 | ||
Early B-cell differentiation in Merkel cell carcinomas: clues to cellular ancestry | Q45333097 | ||
Merkel cell carcinoma patients presenting without a primary lesion have elevated markers of immunity, higher tumor mutation burden and improved survival. | Q47300122 | ||
Merkel cell carcinoma and melanoma: etiological similarities and differences. | Q50638833 | ||
Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. | Q55033112 | ||
Merkel cell carcinoma and HIV infection. | Q55035696 | ||
Sustained Remission of Metastatic Merkel Cell Carcinoma with Treatment of HIV Infection | Q55559005 | ||
Trabecular carcinoma of the skin: an ultrastructural study | Q67415556 | ||
Cutaneous neuroendocrine (Merkel cell) carcinoma: an immunophenotypic, clinicopathologic, and flow cytometric study | Q69528009 | ||
Neuroendocrine carcinoma of the skin (Merkel cell carcinoma). An immunoelectron-microscopic case study | Q71619425 | ||
Neural cell adhesion molecule immunoreactivity in Merkel cells and Merkel cell tumours | Q72294060 | ||
Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites | Q73093416 | ||
Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites | Q73738791 | ||
Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation | Q77458052 | ||
Presence of putative stem cells in Merkel cell carcinomas | Q84201711 | ||
A better prognosis for Merkel cell carcinoma of unknown primary origin | Q87059430 | ||
Merkel cell carcinoma: changing incidence trends | Q28299460 | ||
Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma | Q33413636 | ||
Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults | Q33636436 | ||
Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases | Q33944415 | ||
Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution | Q33983192 | ||
Replication, gene expression and particle production by a consensus Merkel Cell Polyomavirus (MCPyV) genome. | Q34117206 | ||
Trabecular Carcinoma of the Skin | Q34226403 | ||
CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study. | Q34240920 | ||
Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data | Q34241274 | ||
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. | Q34866209 | ||
Risk of merkel cell carcinoma after solid organ transplantation | Q35029320 | ||
A comparison of merkel cell carcinoma and melanoma: results from the california cancer registry. | Q35181020 | ||
Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood. | Q35510910 | ||
Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies | Q35831412 | ||
The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma. | Q36070575 | ||
Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential | Q36468289 | ||
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. | Q36585604 | ||
Merkel cell polyomavirus is frequently detected in korean patients with merkel cell carcinoma | Q36871920 | ||
Merkel cell carcinoma: a virus-induced human cancer | Q37067101 | ||
Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma | Q37321033 | ||
PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival | Q37454288 | ||
Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review | Q37604996 | ||
Complete spontaneous regression of metastatic merkel cell carcinoma: a case report and review of the literature | Q37762413 | ||
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial | Q38378516 | ||
Incidence trends of squamous cell and rare skin cancers in the Swedish national cancer registry point to calendar year and age-dependent increases | Q38446771 | ||
Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System | Q38838916 | ||
Complete spontaneous regression of Merkel cell carcinoma (1986-2016): a 30 year perspective | Q38946809 | ||
Complete Spontaneous Regression of Merkel Cell Carcinoma After Biopsy: A Case Report and Review of the Literature | Q38985346 | ||
Reviewing the current evidence supporting early B-cells as the cellular origin of Merkel cell carcinoma | Q39426361 | ||
Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease | Q39693345 | ||
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. | Q39926027 | ||
Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection. | Q40463395 | ||
Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas. | Q40491492 | ||
Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. | Q41991356 | ||
Merkel cell carcinoma of lymph node with unknown primary has a significantly lower association with Merkel cell polyomavirus than its cutaneous counterpart | Q42244195 | ||
Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers | Q42278531 | ||
The prevalence of Merkel cell polyomavirus in Japanese patients with Merkel cell carcinoma | Q42436038 | ||
P921 | main subject | immunotherapy | Q1427096 |
Merkel cell carcinoma | Q1711744 | ||
P304 | page(s) | 48 | |
P577 | publication date | 2018-03-06 | |
P1433 | published in | Frontiers in Oncology | Q26839986 |
P1476 | title | Merkel Cell Carcinoma: An Update and Immunotherapy. | |
P478 | volume | 8 |
Q64070454 | A rare case of Merkel cell carcinoma with ovarian metastasis |
Q58761272 | Cellular sheddases are induced by Merkel cell polyomavirus small tumour antigen to mediate cell dissociation and invasiveness |
Q58699649 | Prognostic Factors in Merkel Cell Carcinoma: A Retrospective Single-Center Study in 90 Patients |
Q64071981 | Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab |
Search more.